Peginterferon λ for the treatment of patients admitted to hospital with COVID-19: a phase 2, placebo-controlled randomized trial. - Kandel C; Biondi MJ; Gillrie M; Taylor M; Barber B; Amiri L; Robinson T; Powis J; Adhikari NK; Kozak RA; Zahoor MA; Smookler D; et al. (Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2025)